Hyperdynamics Corporation (NYSE:HDY) skyrocketed 72.48% after the company announced that Tullow Guinea provided notice to the Government of Guinea and the other members of the Consortium that Tullow has lifted, with effect from May 3, its declaration of Force Majeure under the Production Sharing Contract, or PSC, and the Joint Operating Agreement. Hyperdynamics Corporation (NYSE:HDY) shares after opening at $2.09 moved to $4.57 on last trade day and at the end of the day closed at $ 4.46 . Company price to cash ratio in past twelve months was calculated as 2.83. Hyperdynamics Corporation (NYSE:HDY) showed a positive weekly performance of 248.44%.
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) extended the terms of employment until December 31, 2016 for each of its executive officers other than Harvey J. Berger, M.D., Chairman and Chief Executive Officer, and Hugh M. Cole, Senior Vice President, Chief Business Officer, whose terms of employment already extend until December 31, 2016. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares moved up 5.53% in last trading session and was closed at $7.63 while trading in range of $7.26 – $7.73 – Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) year to date (YTD) performance is 11.88%.
B/E Aerospace Inc (NASDAQ:BEAV)’s share price rose 10.5% during trading on Monday after RBC Capital raised their price target on the stock from $102.00 to $112.00, StockRatingsNetwork.com reports. RBC Capital currently has an outperform rating on the stock. B/E Aerospace traded as high as $100.25 and last traded at $98.33, with a volume of 5,891,542 shares trading hands. Analysts at Jefferies Group raised their price target on shares of B/E Aerospace from $95.00 to $107.00 in a research note on Monday. Separately, analysts at Canaccord Genuity raised their price target on shares of B/E Aerospace from $98.00 to $100.00 in a research note on Thursday, April 24th. B/E Aerospace Inc (NASDAQ:BEAV) weekly performance is 9.00%. On last trading day company shares ended up $97.22. B/E Aerospace Inc (NASDAQ:BEAV) distance from 50-day simple moving average (SMA50) is -2.38%. Analysts mean target price for the company is $9.06.